Topics
Research & Innovation
-
Wednesday - May 15, 2013
Not intended for U.S. and UK Media
Bayer Initiates Phase III Trial of Regorafenib in Patients with Advanced Liver Cancer » more
-
Tuesday - May 7, 2013
Sustainable Development Report 2012:
Bayer documents economic, social and ecological performance
Bayer CEO Dekkers: “Innovation and sustainability are the driving force behind our business success” / Integrated reporting from 2014 » more
-
Friday - April 26, 2013
Dr. Marijn Dekkers at the Annual Stockholders’ Meeting of Bayer AG:
“Bayer is a world-class innovation company”
2012 operationally a very successful year / Highest sales in the company’s 150-year history / Proposal to raise dividend for 2012 to EUR 1.90 per share / Employees to benefit from the company’s success with bonuses totaling over EUR 700 million / Life Sciences off to a good start in anniversary year » more
-
Thursday - April 25, 2013
World Malaria Day 2013:
Innovative solutions from Bayer CropScience to combat malaria
Vector control portfolio protected millions of lives in 2012 / Important role of public-private partnerships and research collaborations / Training and education of local communities » more
-
Wednesday - April 10, 2013
Immunotherapies against cancer:
Bayer HealthCare to broaden strategic alliance with German Cancer Research Center
Joint immunotherapy research laboratory at the National Center for Tumor Diseases (NCT) in Heidelberg / Operations at the joint laboratory scheduled to start in the middle of 2013 / Additional investments of up to €3 million per year » more
-
Friday - April 5, 2013
Not intended for U.S. and UK Media - 104th Annual Meeting American Association for Cancer Research
Bayer to Present New Data on Growing Oncology Pipeline
New Preclinical and Early Clinical Data Evaluating Innovative Compounds in Drug Development / Numerous Oral and Poster Presentations Highlight Bayer’s Advancing Oncology Portfolio » more
-
Thursday - March 7, 2013
Not intended for U.S. and UK Media
Bayer to collaborate with the Children’s Hospital & Research Center Oakland to fight rare blood diseases
Focus on sickle cell anemia / Bayer’s Mission Bay-based scientists to join one of the largest sickle cell programs in the U.S. » more
-
Friday - February 22, 2013
New award from the Bayer Science & Education Foundation:
Bayer Thrombosis Research Award 2013 for Dr. Krystin Krauel
Research scientist at Ernst-Moritz-Arndt University Greifswald honored for her work in the field of antibacterial host defenses » more
-
Tuesday - February 19, 2013
Not intended for U.S. and UK Media
Bayer and Regeneron Initiate Phase III Trial of VEGF Trap-Eye (Aflibercept) for the Treatment of Diabetic Macular Edema in Asia and Russia » more
-
Wednesday - February 13, 2013
Not intended for U.S. and UK Media - Castration-Resistant Prostate Cancer with Bone Metastases:
Radium-223 Dichloride Granted Priority Review by U.S. FDA » more
-
Thursday - February 7, 2013
European Innovative Medicines Initiative (IMI):
Bayer supports innovative drug discovery in Europe
Bayer HealthCare to coordinate international consortium “European Lead Factory” aiming at jointly discovering new medicines » more
-
Friday - January 25, 2013
Bayer foundation cooperates with Humboldt Foundation
EUR 3 million for new Humboldt-Bayer research fellowships
Financing for 10 post-doctoral fellowships a year through 2018 / Focus on the life sciences, chemistry and pharmacy » more
-
Thursday - January 17, 2013
Dr. Thomas Steckenreiter to become head of Operation Support & Safety at Bayer Technology Services
Dr. Norbert Kuschnerus to retire » more
-
Thursday - January 17, 2013
Not intended for U.S. and UK Media - Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI) 2013:
Data for Bayer’s Stivarga® (regorafenib) to be Presented at 2013 ASCO-GI Congress
New analyses from the Phase III CORRECT study of regorafenib in the treatment of metastatic colorectal cancer to be presented / Phase I study in hepatocellular carcinoma with regorafenib to be presented » more
-
Thursday - January 10, 2013
Awards from the Bayer Science & Education Foundation
Bayer Early Excellence in Science Award 2012: EUR 30,000 for young research scientists
Dr. Christiane Opitz (German Cancer Research Center, Heidelberg) wins the „Biology“ category / Dr. Nuno Maulide (Max Planck Institut für Kohlenforschung, Mühlheim an der Ruhr) takes the „Chemistry“ award / Dr. Volker Presser (Leibniz Institute for New Materials, Saarbrücken) awarded prize in the „Materials“ field » more
-
Thursday - January 3, 2013
Not intended for U.S. and UK media
Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival in Patients with Radioactive Iodine Refractory Differentiated Thyroid Cancer » more
-
Wednesday - December 12, 2012
Not intended for U.S. and UK Media
Bayer Submits Radium-223 Dichloride for EU Marketing Authorization for the Treatment of Castration-Resistant Prostate Cancer with Bone Metastases » more
-
Thursday - November 29, 2012
European Innovative Medicines Initiative (IMI):
Bayer supports pharmaceutical research in Europe
Bayer HealthCare and Leiden University coordinate consortium to optimize binding kinetics for drug candidates » more
-
Wednesday - November 28, 2012
New edition of research, the Bayer Scientific Magazine, published
Improving people’s lives through innovation
Systematic biotechnology: life science research for new therapies and a reliable food supply / Potatoes: head start for young tubers / Catalysis: turbocharged chemistry for innovative molecules » more
-
Wednesday - November 21, 2012
Symposium on “New Ways in Weed Control Research”:
“Agriculture worldwide needs new solutions” Scientists call for urgent turnaround in weed-control research
Growing weed resistance in all major production areas of the world / More than 25-year lull in bringing herbicides with new modes of action to market » more
Copyright @ Bayer AG
Search
Publications
research – The Bayer Scientific Magazine
Stockholders' Newsletter
Annual Report
Sustainable Development Report
Publications Overview
Newsletter
Events
Download Center - Selection